The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Photovoltaic Restoration of Central Vision in Atrophic Age-Related Macular Degeneration
Open accessAbstract
PURPOSE: Loss of photoreceptors in atrophic age-related macular degeneration results in severe visual impairment, although some peripheral vision is retained. To restore central vision without compromising the residual peripheral field, we developed a wireless photovoltaic retinal implant (PRIMA; Pixium Vision, Paris, France) in which pixels convert images projected from video glasses using near-infrared light into electric current to stimulate the nearby inner retinal neurons. DESIGN: We carried out a first-in-human clinical trial to test the safety and efficacy of the prosthesis in patients with geographic atrophy (ClinicalTrials.gov identifier, NCT03333954). PARTICIPANTS: Five patients with geographic atrophy zone of at least 3 optic disc diameters, no foveal light perception, and best-corrected visual acuity of 20/400 to 20/1000 in the worse-seeing study eye. METHODS: The 2-mm wide, 30-μm thick chip, containing 378 pixels (each 100 μm in diameter), was implanted subretinally in the area of atrophy (absolute scotoma). MAIN OUTCOME MEASURES: Anatomic outcomes were assessed with fundus photography and OCT for up to 12 months of follow-up. Prosthetic vision was assessed by mapping light perception, bar orientation, letter recognition, and Landolt C acuity. RESULTS: In all patients, the prosthesis was implanted successfully under the macula, although in 2 patients, it was implanted in unintended locations: within the choroid and off center by 2 mm. All 5 patients could perceive white-yellow prosthetic visual patterns with adjustable brightness in the previous scotomata. The 3 with optimal placement of the implant demonstrated prosthetic acuity of 20/460 to 20/550, and the patient with the off-center implant demonstrated 20/800 acuity. Residual natural acuity did not decrease after implantation in any patient. CONCLUSIONS: Implantation of the PRIMA did not decrease the residual natural acuity, and it restored visual sensitivity in the former scotoma in each of the 5 patients. In 3 patients with the proper placement of the chip, prosthetic visual acuity was only 10% to 30% less than the level expected from the pixel pitch (20/420). Therefore, the use of optical or electronic magnification in the glasses as well as smaller pixels in future implants may improve visual acuity even further.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“testing showed a good correlation between the number of stimulators and visual acuity, achieving a visual resolution of approximately 1.2 pixels.”
From Visual Prostheses in the Era of Artificial Intelligence Technology (2025) · cites this paper as [35]
The cited source says what the claim attributes to it.
In the citing paper
“By this metric, comparison of visual acuity with the device switched ON and OFF showed improvement only for the PRIMA35 and Argus II9 devices.”
From Visual Prostheses in the Era of Artificial Intelligence Technology (2025) · cites this paper as [35]
In the citing paper
“Devices have a size providing a maximum restored visual angle of about 10 • , suitable only for applications where a small part of the visual field is lost, such as AMD [48,49].”
From Advances in visual prostheses: engineering and biological challenges (2022) · cites this paper as [48]
In the citing paper
“The highest visual acuities reported to date, as measured with the Landolt-C test, were 20/460 with the subretinal implant PRIMA (in AMD patients) [48] and 20/546 with the subretinal implant Alpha-AMS (in RP patients) [133].”
From Advances in visual prostheses: engineering and biological challenges (2022) · cites this paper as [48]
In the citing paper
“However, this ideal case is rarely reached and has only been reported for the PRIMA device [48] and some patients with Alpha IMS, most likely with preserved eye movements [154].”
From Advances in visual prostheses: engineering and biological challenges (2022) · cites this paper as [48]
In the citing paper
“So far, flicker fusion has been achieved only for the PRIMA device in AMD patients [48].”
From Advances in visual prostheses: engineering and biological challenges (2022) · cites this paper as [48]
In the citing paper
“Photovoltaic retinal prostheses [48] were the first example of neurostimulation devices providing fully wireless electrical stimulation to the nervous system without the need for implantable batteries or active electronic units.”
From Advances in visual prostheses: engineering and biological challenges (2022) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,545
Prevalence of Age-Related Macular Degeneration in the United States
The Eye Diseases Prevalence Research Group* (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,783
The Freiburg Visual Acuity Test???Automatic Measurement of Visual Acuity
Bach, M. (1996) · Optometry and Vision Science · doi:10.1097/00006324-199601000-00008 · Cited by 998
Subretinal electronic chips allow blind patients to read letters and combine them to words
Zrenner, E., Bartz-Schmidt, K. U., Benav, H., Besch, D., Bruckmann, A., Gabel, V.-P., Gekeler, F., Greppmaier, U., Harscher, A., Kibbel, S., et al. (2011) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2010.1747 · Cited by 819
Interim results from the international trial of Second Sight's visual prosthesis
Humayun, M. S., Dorn, J. D., da Cruz, L., Dagnelie, G., Sahel, J.-A., Stanga, P. E., Cideciyan, A. V., Duncan, J. L., Eliott, D., Filley, E., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.09.028 · Cited by 700
Self-citationPhotovoltaic retinal prosthesis with high pixel density
Mathieson, K., Loudin, J., Goetz, G. A., Huie, P., Wang, L., Kamins, T. I., Galambos, L., Smith, R., Harris, J. S., Sher, A., et al. (2012) · Nature Photonics · doi:10.1038/nphoton.2012.104 · Cited by 460
Self-citationSubretinal visual implant alpha IMS - clinical trial interim report
Stingl, K., Bartz-Schmidt, K. U., Besch, D., Chee, C. K., Cottriall, C. L., Gekeler, F., Groppe, M., Jackson, T. L., MacLaren, R. E., Koitschev, A., et al. (2015) · Vision Research · doi:10.1016/j.visres.2015.03.001 · Cited by 387
Morphometric analysis of the extramacular retina from postmortem eyes with retinitis pigmentosa.
Humayun, M. S., Prince, M. R., de Juan, E., Barrón, Y., Moskowitz, M., Klock, I. B., & Milam, A. H. (1999) · PubMed · Cited by 366
da Cruz, L., Coley, B. F., Dorn, J., Merlini, F., Filley, E., Christopher, P., Chen, F. K., Wuyyuru, V., Sahel, J., Stanga, P., et al. (2013) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-301525 · Cited by 359
Self-citationThe Argus® II Retinal Prosthesis System
Luo, Y. H.-L., & da Cruz, L. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.09.003 · Cited by 351
Cited by
Sorted by citations
Simultaneous perception of prosthetic and natural vision in AMD patients
Palanker, D., Le Mer, Y., Mohand-Said, S., & Sahel, J. A. (2022) · Nature Communications · doi:10.1038/s41467-022-28125-x · Cited by 140
“In the fi rst phase of the trial 11 , prosthetic vision was assessed independently from the remaining natural vision.”
BackgroundMethodInfluentialSelf-citationChenais, N. A. L., Airaghi Leccardi, M. J. I., & Ghezzi, D. (2021) · Communications Materials · doi:10.1038/s43246-021-00133-2 · Cited by 110
Regenerative and restorative medicine for eye disease
Gelder, R. N. V., Chiang, M. F., Dyer, M. A., Greenwell, T. N., Levin, L. A., Wong, R., & Svendsen, C. N. (2022) · Nature Medicine · doi:10.1038/s41591-022-01862-8 · Cited by 111
Metaverse Wearables for Immersive Digital Healthcare: A Review
Kim, K., Yang, H., Lee, J.-H., & Lee, W. G. (2023) · Advanced Science · doi:10.1002/advs.202303234 · Cited by 110
Bioengineering strategies for restoring vision
Cehajic-Kapetanovic, J., Singh, M. S., Zrenner, E., & MacLaren, R. E. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00836-4 · Cited by 79
Metadata
- Authors
- Palanker, D., Le Mer, Y., Mohand-Said, S., Muqit, M., & Sahel, J. A.
- Affiliations
- Stanford University (US)
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- Corresponding author
- Palanker, Daniel
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2020-08
- Volume
- 127
- Issue
- 8
- Pages
- 1097-1104
- ISSN
- 0161-6420 (ISSN-L)
- PMC
- PMC7384969
- OpenAlex
- W3006860701
- Cited by
- 227
- References
- 36
- Citations by year
- 2026: 31 · 2025: 29 · 2024: 26 · 2023: 37 · 2022: 37 · 2021: 44 · 2020: 22
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Ophthalmology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neural Engineering
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- dry age-related macular degeneration, geographic atrophy, PRIMA, subretinal implantation, scotoma, photoreceptor loss, implant safety and efficacy, pixel pitch
- MeSH terms
- Electrodes, Implanted, Feasibility Studies, Female, Humans, Macula Lutea, Macular Degeneration, Male, Middle Aged, Visual Perception, Recovery of Function, Tomography, Optical Coherence, Visual Prosthesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
